As of May 2026 Allogene Therapeutics has a market cap of NZ$1.23 Billion. This makes Allogene Therapeutics the world's 6716th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 25th, 2026 the market cap of Allogene Therapeutics was reported to be: